These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23375423)

  • 1. [Psychiatric disorders associated with montelukast: data from the National Pharmacovigilance Database].
    Marchand MS; Jonville-Béra AP; Autret-Leca E;
    Arch Pediatr; 2013 Mar; 20(3):269-73. PubMed ID: 23375423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reports of suicidality in clinical trials of montelukast.
    Philip G; Hustad C; Noonan G; Malice MP; Ezekowitz A; Reiss TF; Knorr B
    J Allergy Clin Immunol; 2009 Oct; 124(4):691-6.e6. PubMed ID: 19815114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatric Disorders and Montelukast in Children: A Disproportionality Analysis of the VigiBase(®).
    Aldea Perona A; García-Sáiz M; Sanz Álvarez E
    Drug Saf; 2016 Jan; 39(1):69-78. PubMed ID: 26620206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of behavior-related adverse experiences in clinical trials of montelukast.
    Philip G; Hustad CM; Malice MP; Noonan G; Ezekowitz A; Reiss TF; Knorr B
    J Allergy Clin Immunol; 2009 Oct; 124(4):699-706.e8. PubMed ID: 19815116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-marketing safety concerns with montelukast: A pharmacovigilance study based on the FDA adverse event reporting system.
    Ou Z; Han Y; Zhuang W; Xiao Y; Cai S; Zhang X
    Int J Clin Pharmacol Ther; 2024 Nov; 62(11):497-506. PubMed ID: 39099387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Montelukast and psychiatric disorders in children.
    Wallerstedt SM; Brunlöf G; Sundström A; Eriksson AL
    Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):858-64. PubMed ID: 19551697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing risk: Data from montelukast clinical trials.
    Kelsay K
    J Allergy Clin Immunol; 2009 Oct; 124(4):697-8. PubMed ID: 19815115
    [No Abstract]   [Full Text] [Related]  

  • 8. Rate of suicide in patients taking montelukast.
    Jick H; Hagberg KW; Egger P
    Pharmacotherapy; 2009 Feb; 29(2):165-6. PubMed ID: 19170586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse drug reactions of montelukast in children and adults.
    Haarman MG; van Hunsel F; de Vries TW
    Pharmacol Res Perspect; 2017 Oct; 5(5):. PubMed ID: 28971612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant medication dispensing among montelukast initiators.
    Zhou EH; Kaplan S; Mosholder A; Moeny D; Ding Y; Wu Y; Iyasu S; Hammad TA
    J Asthma; 2013 Nov; 50(9):990-5. PubMed ID: 23841530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nightmares induced by montelukast in children and adults.
    Cereza G; Garcia Doladé N; Laporte JR
    Eur Respir J; 2012 Dec; 40(6):1574-5. PubMed ID: 23204025
    [No Abstract]   [Full Text] [Related]  

  • 12. Exploring the possible association between montelukast and neuropsychiatric events among children with asthma: a matched nested case-control study.
    Ali MM; O'Brien CE; Cleves MA; Martin BC
    Pharmacoepidemiol Drug Saf; 2015 Apr; 24(4):435-45. PubMed ID: 25683909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Montelukast and Neuropsychiatric Events in Children with Asthma: A Nested Case-Control Study.
    Glockler-Lauf SD; Finkelstein Y; Zhu J; Feldman LY; To T
    J Pediatr; 2019 Jun; 209():176-182.e4. PubMed ID: 30905424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serious adverse reactions of bupropion for smoking cessation: analysis of the French Pharmacovigilance Database from 2001 to 2004.
    Beyens MN; Guy C; Mounier G; Laporte S; Ollagnier M
    Drug Saf; 2008; 31(11):1017-26. PubMed ID: 18840021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of montelukast for treatment of asthma in cigarette smokers.
    Price D; Popov TA; Bjermer L; Lu S; Petrovic R; Vandormael K; Mehta A; Strus JD; Polos PG; Philip G
    J Allergy Clin Immunol; 2013 Mar; 131(3):763-71. PubMed ID: 23380218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Montelukast].
    Münzel F; Mühlhäuser U; Eschenhagen T
    Dtsch Med Wochenschr; 2002 Nov; 127(44):2337-9. PubMed ID: 12410440
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions.
    Bisgaard H; Skoner D; Boza ML; Tozzi CA; Newcomb K; Reiss TF; Knorr B; Noonan G
    Pediatr Pulmonol; 2009 Jun; 44(6):568-79. PubMed ID: 19449366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Montelukast-induced metamorphopsia in a pediatric patient: A case report and a pharmacovigilance database analysis.
    Carnovale C; Gentili M; Antoniazzi S; Radice S; Clementi E
    Ann Allergy Asthma Immunol; 2016 Apr; 116(4):370-1. PubMed ID: 26874930
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
    Virchow JC; Bachert C
    Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Churg-Strauss syndrome after treatment with Singulair (montelukast)].
    Hammer HB; Aukrust P; Frøland SS
    Tidsskr Nor Laegeforen; 2002 Feb; 122(5):484-6. PubMed ID: 11961976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.